165 related articles for article (PubMed ID: 28498301)
1. Seroprevalence of Hepatitis A Twelve Years After the Implementation of Toddlers' Vaccination: A Population-Based Study in Israel.
Bassal R; Weil M; Cohen D; Sofer D; Mendelson E; Shohat T
Pediatr Infect Dis J; 2017 Oct; 36(10):e248-e251. PubMed ID: 28498301
[TBL] [Abstract][Full Text] [Related]
2. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
3. Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong Province, China: A comparison between 2006 and 2014.
Yan BY; Lv JJ; Liu JY; Feng Y; Wu WL; Xu AQ; Zhang L
Int J Infect Dis; 2019 May; 82():129-134. PubMed ID: 30862519
[TBL] [Abstract][Full Text] [Related]
4. Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule.
Galor I; Perry Markovich M; Wolf D; Haber M; Hartal M; Avramovich E
Vaccine; 2020 Feb; 38(7):1593-1596. PubMed ID: 31932135
[TBL] [Abstract][Full Text] [Related]
5. Incidence of hepatitis A in Israel following universal immunization of toddlers.
Dagan R; Leventhal A; Anis E; Slater P; Ashur Y; Shouval D
JAMA; 2005 Jul; 294(2):202-10. PubMed ID: 16014594
[TBL] [Abstract][Full Text] [Related]
6. Long-term trends in hepatitis A incidence following the inclusion of Hepatitis A vaccine in the routine nationwide immunization program.
Chodick G; Heymann AD; Ashkenazi S; Kokia E; Shalev V
J Viral Hepat; 2008 Oct; 15 Suppl 2():62-5. PubMed ID: 18837837
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China.
Zhang ZL; Zhu XJ; Shan AL; Gao ZG; Zhang Y; Ding YX; Liu H; Wu WS; Liu Y; He HY; Xie XH; Xia WD; Li C; Xu WT; Li ZY; Lin HL; Fu WM
Hum Vaccin Immunother; 2014; 10(4):1008-12. PubMed ID: 24503599
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
[TBL] [Abstract][Full Text] [Related]
11. [Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)].
Li JP; Gao ZX; Zhou J
Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):238-40. PubMed ID: 20726266
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination.
Chironna M; Prato R; Sallustio A; Martinelli D; Tafuri S; Quarto M; Germinario C
BMC Infect Dis; 2012 Oct; 12():271. PubMed ID: 23098290
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of hepatitis E virus in dromedary camels, Bedouins, Muslim Arabs and Jews in Israel, 2009-2017.
Bassal R; Wax M; Shirazi R; Shohat T; Cohen D; David D; Abu-Mouch S; Abu-Ghanem Y; Mendelson E; Ben-Ari Z; Mor O
Epidemiol Infect; 2019 Jan; 147():e92. PubMed ID: 30869027
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination.
Almuneef MA; Memish ZA; Balkhy HH; Qahtani M; Alotaibi B; Hajeer A; Qasim L; Al Knawy B
Vaccine; 2006 Jul; 24(27-28):5599-603. PubMed ID: 16757065
[TBL] [Abstract][Full Text] [Related]
15. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel.
Chodick G; Green MS; Heymann AD; Rosenmann L; Shalev V
Prev Med; 2007 Nov; 45(5):386-91. PubMed ID: 17599401
[TBL] [Abstract][Full Text] [Related]
16. Routine testing for IgG antibodies against hepatitis A virus in Israel.
Samuels N
BMC Public Health; 2005 Jun; 5():60. PubMed ID: 15935104
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis A immunity in Yozgat, Turkey.
Kader Ç; Göçmen AY; Demir MI; Çolak NY; Gök SE; Arkan FI; Sara MY; Erbay A
Ann Saudi Med; 2019; 39(1):37-41. PubMed ID: 30712049
[TBL] [Abstract][Full Text] [Related]
18. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
[TBL] [Abstract][Full Text] [Related]
19. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea].
Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH
Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
